Macrophage increases Series A financing

Macrophage Pharma Ltd has topped up a Series A financing round announced in January with an investment from Merck Ventures BV, a subsidiary of Merck KGaA. The size of the investment is reportedly £3 million, bringing the total raised in the A round up to £12 million.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom